200
Participants
Start Date
November 25, 2024
Primary Completion Date
February 28, 2026
Study Completion Date
September 30, 2026
Nicotinamide Riboside Malate
Active supplement.
Placebo
Placebo
Mayo Clinic in Rochester, Rochester
Lead Sponsor
Mayo Clinic
OTHER